Caplin Point Laboratories Limited (BOM: 524742)

Caplin Point Laboratories Income Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Operating Revenue	18,308	16,941	14,667	12,694	10,613	8,632
Other Revenue	20.1	20.1	15.9	15.4	10.6	7.57
Revenue	18,328	16,961	14,683	12,710	10,624	8,640
Revenue Growth (YoY)	16.86%	15.51%	15.53%	19.64%	22.96%	33.12%
Cost of Revenue	7,877	7,561	6,792	5,724	4,806	4,205
Gross Profit	10,451	9,400	7,891	6,986	5,817	4,434
Selling, General & Admin	1,580	1,437	1,371	1,154	1,026	677.74
Research & Development	737.2	737.2	631.9	592.7	536.9	530.14
Other Operating Expenses	2,065	1,683	1,456	1,275	952	617.85
Operating Expenses	5,011	4,391	3,908	3,489	2,884	2,142
Operating Income	5,440	5,009	3,984	3,496	2,933	2,292
Interest Expense	-5.8	-7.8	-7.8	-7	-15.9	-3.2
Interest & Investment Income	472.8	472.8	354.1	235	186.1	74.58
Earnings From Equity Investments	-	2.7	0.8	-	-	-
Currency Exchange Gain (Loss)	113.1	113.1	138.2	109.8	7.2	273.7
Other Non Operating Income (Expenses)	129.3	60.7	48.2	23	31.5	57.49
EBT Excluding Unusual Items	6,149	5,651	4,517	3,857	3,142	2,695
Gain (Loss) on Sale of Assets	-6.5	-6.5	-3.6	1.2	-6	-0.43
Pretax Income	6,143	5,644	4,514	3,858	3,136	2,695
Income Tax Expense	1,175	1,030	743.6	773.7	621.9	543.79
Earnings From Continuing Operations	4,968	4,614	3,770	3,085	2,514	2,151
Minority Interest in Earnings	-32.2	-43.3	-7.3	-86.1	-91.6	-0.76
Net Income	4,936	4,571	3,763	2,998	2,423	2,150
Net Income to Common	4,936	4,571	3,763	2,998	2,423	2,150
Net Income Growth	18.10%	21.48%	25.49%	23.76%	12.68%	21.77%
Shares Outstanding (Basic)	76	76	76	76	76	76
Shares Outstanding (Diluted)	76	76	77	76	76	76
Shares Change (YoY)	-0.10%	-0.26%	0.18%	0.07%	0.11%	0.32%
EPS (Basic)	64.98	60.19	49.62	39.61	32.03	28.42
EPS (Diluted)	64.65	59.90	49.18	39.26	31.71	28.20
EPS Growth	18.22%	21.80%	25.27%	23.81%	12.45%	21.39%
Free Cash Flow	2,310	1,726	779	2,456	1,953	-320.61
Free Cash Flow Per Share	30.26	22.61	10.18	32.15	25.59	-4.21
Dividend Per Share	2.500	5.000	4.500	4.000	3.000	2.500
Dividend Growth	-50.00%	11.11%	12.50%	33.33%	20.00%	13.64%
Gross Margin	57.02%	55.42%	53.74%	54.96%	54.76%	51.32%
Operating Margin	29.68%	29.53%	27.13%	27.51%	27.61%	26.53%
Profit Margin	26.93%	26.95%	25.63%	23.59%	22.81%	24.89%
Free Cash Flow Margin	12.60%	10.17%	5.31%	19.32%	18.38%	-3.71%
EBITDA	6,033	5,507	4,399	3,939	3,285	2,597
EBITDA Margin	32.92%	32.47%	29.96%	30.99%	30.92%	30.06%
D&A For EBITDA	593	497.2	415.8	442.3	351.5	304.2
EBIT	5,440	5,009	3,984	3,496	2,933	2,292
EBIT Margin	29.68%	29.53%	27.13%	27.51%	27.61%	26.53%
Effective Tax Rate	19.13%	18.25%	16.48%	20.05%	19.83%	20.18%
Revenue as Reported	19,046	17,610	15,227	13,082	10,848	9,045

Source: S&P Capital IQ. Standard template. Financial Sources.